To define the role of specific gene deletions and mutations in the development of transplant arteriosclerosis, we generated an accelerated model of the disease in mice. Carotid arteries were transplanted between B.1OA(2R) (H-2h2) donor mice and C57BL/6J (H-2b) recipients and compared with arteries isografted between H-2b mice. Immunosuppressive drugs were not used. Within 7 days, the allografted carotid artery formed a neointima composed of mononuclear leukocytes (CD45 +) that were predominantly monocytes or macrophages (ie, CD1 lb+ cells with single-lobed nuclei). CD4+ and CD8+ cells were present as well. By 30 days, the neointima became exuberant, and mononuclear leukocytes were largely replaced by smooth muscle cells. Cells staining for proliferating-cell nuclear antigen were abundantly present in the intima at both early and late time points, indicating the proliferation of mononuclear leukocytes and smooth muscle cells. The area of the intima increased from day 7 to day 30 (P<.0005), as did the number of nuclei (P=.0005), but the density of the nuclei decreased (P=.02), suggesting the formation of extracellular matrix. Six of the eight isografts formed no neointima, and in samples from the remaining two, a single layer of smooth muscle neointimal cells covered just a portion of the vessel circumference. This model, which reproduces many of the features of human transplant arteriosclerosis but at an accelerated pace, should prove useful for determining the roles in transplant arteriosclerosis of genes that code for components of immunologic and inflammatory responses. (Circ Res. 1994;75:199-207.) 
T ransplant-associated arteriosclerosis is the major cause of cardiac allograft failure after the first postoperative year, 12 and it appears to be a significant problem in the long-term survival of other solid organ transplants.34 Also, despite the success of immunosuppressive agents in the treatment of acute rejection, there is considerable debate about whether these drugs influence the progression of transplant arteriosclerosis in animal models.5-8 Both the gross and the histological features of transplant arteriosclerosis differentiate it from commonly occurring (chronic) arteriosclerosis. In contrast with common arteriosclerosis, the lesion associated with transplant arteriosclerosis involves the artery in a concentric rather than eccentric fashion and often involves both the epicardial coronary arteries and the intramyocardial branches.' Lipid accumulation is less common in the early development of the transplant-associated lesion,9 and the tempo of the disease is faster. 2 Although the complexity of the transplant-associated lesion and the many cell types involvedas well as the likely participation of a variety of growth factors and cytokinessuggest stimulation by an immune mechanism, such as delayed-type hypersensitivity,10 it has not been possible to assign a unitary pathogenic mechanism to the disease.
Many animal models that manifest lesions resembling those of human arteriosclerosis have been developed8"1-'7 have not helped to clarify the underlying mechanism of the disease. A major opportunity, not yet explored, for defining the detailed pathogenesis of transplant arteriosclerosis can now be found in the study of mice subjected to specific gene deletions.
The past several years have witnessed the creation of a remarkable number of mouse strains in which genes central to the immune and inflammatory systems have been mutated. 25 If one were to study transplant arteriosclerosis in such strains, it should be possible to define the specific relations of many genes and cell types to the pathogenesis of this lesion. For example, it has been postulated that major histocompatibility complex (MHC) class II antigen expression in the endothelial cells of transplanted vessels initiates the arteriosclerotic process. 26 It is now possible to study mice that do not express MHC class II antigens and lack CD4+ T cells.27 '28 Mice are also available that do not express MHC class I antigens (and lack CD8+ T cells),29'30 that do not express class I or class II antigens (and lack both CD4+ and CD8+ T cells),31 and that have deficient macrophage function32 or lack B lymphocytes (nu)33 and natural killer cells (bg). 33 There are also mice that cannot rearrange the variable regions of immunoglobulins or T-cell receptors. 34 We describe in the present study a simple model that can be used to exploit the opportunities represented by these mouse strains with immune or inflammatory cell deficiencies. The carotid artery is transplanted between pairs of inbred mice in syngeneic and allogeneic combinations, in the absence of immunosuppressive agents. In the allogeneic transplant, an intimal lesion is manifest within 7 days, and it grows to a florid, at times nearly 
Materials and Methods Animals
Two strains of inbred mice (28 to 32 g, 9- week-old males) were chosen for incompatibility in the H-2 region (Jackson Laboratory). B.1OA(2R) (H-2h2) mice were used as donors in the allograft group, and C57BL/6J (H-2b) mice were used as donors in the isograft group. H-2b mice were used as recipients in both groups.
Transplantation
The operation was performed on anesthetized mice under a dissecting microscope (Wild model M3Z). The recipient was fixed in a supine position with its neck extended. A midline incision was made on the ventral side of the neck from the suprasternal notch to the chin. The left carotid artery was dissected from the bifurcation in the distal end toward the proximal end as far as was technically possible. The artery was then occluded with two microvascular clamps (8 mm long, ROBOZ Surgical Instrument Co), one at each end, and two longitudinal arteriotomies (0.5 to 0.6 mm) were made with a fine (30-gauge) needle and scissors.
In the donor mouse, both the left and right carotid arteries were fully dissected from the arch to the bifurcation. Harvested arteries were preserved in isotonic saline at room temperature (5 to 10 minutes maximum for the first allograft and 30 to 40 minutes maximum for the second). The graft was then transplanted paratopically into the recipient in an endto-side anastomosis with an 11/0 continuous nylon suture under x 16 magnification (Fig 1) . Before the second (distal) anastomosis, the microvascular clamp at the proximal end was released temporarily (1 to 2 seconds) to flush away residual blood inside the lumen. Both clamps were released after the two anastomoses had been completed.
At this point, prominent pulsations should have been visible in both the transplanted loop and the native vessel. If there were no pulsations or they diminished within a few minutes of restoration of blood flow, clot formation at the anastomosis was assumed, and the procedure was terminated and considered a surgical failure. If there were vigorous pulsations in the transplanted vessel, the skin incision was closed with a 4/0 interrupted suture. The grafts were subjected to 30 to 60 minutes of ischemia; our surgical success rate was -90%.
Grafts were harvested by cutting the transplanted loop from the native vessel at the suture lines. Allografts were harvested at 7, 15, and 30 days after transplantation. Isografts were harvested at 30 days only. The proximal half of the trans-planted loop (-2.5 mm) was fixed overnight in methyl Carnoy's fixative, and the other half was frozen in powdered dry ice and embedded in medium (Optimal Cutting Temperature Compound, Miles, Inc). Histological sectioning was begun at the center of the graft to avoid the effects of the suture line.
Forty-two mice were used as recipients of 8 isografts and 34 allografts from 29 donors (some donors provided two arteries for transplantation). All 8 isografts were pulsating at the time of harvest and were included in the analysis. Of the 34 allografts, 6 were not pulsating at the time of harvest and were omitted: 1 at day 7 (1 of 10), 1 at day 15 (1 of 10), and 4 at day 30 (4 of 14). Histological examination showed thrombosis in each case. After harvest, 2 more allografts from day 7 were removed from the study, bringing the total number of allografts to 26. Even though these 2 grafts appeared to pulsate at the time of harvest, histological examination revealed thrombosis. The day-30 allograft loops were thicker and whiter than the day-7 and day-15 loops and showed diminished pulsations. There was no postoperative mortality.
Preparation of Histological Specimens
Tissue samples in methyl Carnoy's fixative were processed for paraffin embedding in an automated system (Hypercenter XP, Shandon Scientific Ltd). Four-micrometer cross sections were cut in a microtome (Jung Biocut model 2035, Leica), rid of paraffin (by melting for 10 minutes at 60°C), washed three times with xylene, and rehydrated in graded ethanol. Frozen specimens (stored at -80°C) were cut to a thickness of 6 gm in a motor-driven cryotome (RMC model CMT-955A) and fixed in cold acetone (-20°C) for 8 minutes before immunostaining.
Immunohistochemistry Paraffin Sections
Proliferating cells were detected with a proliferating-cell nuclear antigen (PCNA) antibody (clone PC10, 3 ag/mL, Oncogen Science); vascular smooth muscle cells, with an antibody against smooth muscle a-actin (anti-NH2-terminal decapeptide, clone 1A4, 1:400, Sigma Chemical Co); and endothelial cells, with a rabbit anti-human von Willebrand factor antibody (lot 128, 1:1000, DAKO). Leukocytes were identified with a purified rat anti-mouse CD45 antibody (clone 30F11.1, 1:1000, Pharmingen). Biotinylated donkey anti-rabbit antibody (RPN 1004, 1:2000, Amersham) was used as a secondary antibody for von Willebrand factor, and biotinylated goat anti-mouse IgG2a antibody (RPN 1181, 1:100, Amersham) was used as a secondary antibody for PCNA and a-actin.
Frozen Sections CD8+ and CD4+ lymphocytes were detected with a rat anti-mouse Ly-2 antibody (clone 53-6.7, 1:50, Pharmingen) and a rat anti-mouse L3T4 antibody (clone RM-4-5, 1:50, Pharmingen), respectively. CDlb+ cells were detected with a mouse antibody to the C3bi receptor (Mac-1 antigen) (clone BMA M1/70.15.1, Accurate Chemical & Scientific Corp). Biotinylated goat anti-rat IgG(H&L) (lot A073-NI63A, 1: 200, Southern Biotechnology Associates, Inc) was used as a secondary antibody for detecting CD4, CD8, and CD11b.
All primary antibodies were applied for 1 to 2 hours in phosphate-buffered saline (PBS) with 1% bovine serum albumin (pH 7.4). All secondary antibodies were applied for 1 hour. Avidin-biotinylated enzyme complex (ABC) peroxidase (Elite Vectastain ABC kit, Vector Laboratories) or ABC alkaline phosphatase (Vectastain ABC kit, Vector Laboratories) was applied for 30 minutes. Nonspecific binding was blocked with normal goat serum (1:10, 20 minutes) before addition of the primary antibody. After addition of the secondary antibody, endogenous peroxidase was blocked with hydrogen peroxide in methanol (2%, 10 minutes). Between each antibody application, all sections were washed three times in PBS (5 minutes each time). Experiments were performed at room temperature.
All sections were labeled by the indirect peroxidase technique according to the manufacturer's instructions (Elite Vectastain ABC kit), followed by developing in 3,3'-diaminobenzidine (Vector Laboratories), except for those treated with antibody to a-actin. These sections were labeled indirectly with alkaline phosphatase and developed with Vec-torRed (Vector Laboratories). Immunohistochemical slides were counterstained with methyl green, except those treated with antibody to a-actin. a-Actin-stained sections were counterstained instead with Verhoeff's stain for elastic tissue (without Ponceau staining). Nuclei were counted after methyl green or hematoxylin staining.
Murine spleen tissue was used as a positive control for CD4, CD8, and CD45. The epithelial crypts of murine small intestine were used as a positive control for PCNA, and native vessels were used as a positive control for a-actin and von Willebrand factor. As negative controls, some sections were incubated in the absence of primary antibody.
Histology and Morphometry
Sections were reviewed by four examiners (C.S., M.E.R., C.B., E.H.) under a Nikon Labophot-2 microscope equipped with a Sony 3CCD camera and television monitor. The intima was defined as the region between the lumen and the internal elastic lamina. The media was defined as the region between the internal and external elastic laminas. Cell counts in the intima and media are expressed as the number of nuclei in the entire cross section of the respective structure. The adventitia (outside the external elastic lamina) varied in size because of differences in surgical dissection. Thus, cell counts in the adventitia are expressed in relation to surface area. Using the IMAGE-1 software (Universal Imaging Corp) on an IBM AT, we measured areas from images obtained at x 100 magnification (Odyssey confocal microscope, Noran Instruments) in a transmitted light mode. Area measurements were made on one section (treated with Verhoeffs elastic stain) from each of the 34 animals studied (26 allografted, 8 isografted) at =500 ,tm from the center of the graft. Areas were recorded in square micrometers (mean±+SD). In the statistical analyses for differences in mean areas, the individual values for the area from each animal at each time point for the allografts (7, 15 and 30 days) and at day 30 for the isografts were averaged.
In qualitative studies of the 34 animals, we examined an additional 9 to 24 sections per animal from the midpoint of the carotid artery loop to the suture line to determine the uniformity of the lesion and whether it was concentric. Similar qualitative studies were performed on 156 consecutive sections from one of the day-7 allografted animals, 177 consecutive sections from one of the day-15 allografted animals, and 204 consecutive sections from one of the day-30 allografted animals. The lesions were concentric in general and asymmetric on occasion, with only modest variations from section to section within a single animal. Near the anastomosis, however, there was greater proliferation of neointima and an increase in adventitial inflammatory infiltrates.
Nuclei were counted in 4-,um hematoxylin-stained paraffin sections (one from each of the 34 animals) that were consecutive to the sections used for the area measurements described above. Values represent the mean±SD for each of the three allograft groups (days 7, 15, and 30) and the one isograft group.
For the detailed immunohistochemical studies, we selected representative sections from 3 isografted vessels and 9 allografted vessels (3 at day 7, 3 at day 15, and 3 at day 30). Both paraffin and frozen sections were prepared from each of the 12 animals in this group. The paraffin sections (4 gm) were consecutive to those used for the area measurements and counting of nuclei. They were stained for a-actin, PCNA, and CD45. The frozen sections (6 ,m) were stained for CD4, CD8, and Mac-1. Like the sections used for the area measurements, the frozen sections were also cut 500 ,um from the center of the arterial loop, but from a portion of the specimen that had not been fixed initially. Finally, single sections from one allografted animal at day 7, one at day 15, and one at day 30, and one isografted animal were stained with antibody to von Willebrand factor.
Cells were counted on the television monitor with a handheld electronic colony counter and are reported as the total number of cells for intimal sections and medial sections (mean±SD) and as the total number of cells per square micrometer (mean±SD) for adventitial sections. Where the number of cells staining with an antibody is given as a percentage, the denominator represents the total number of nuclei counted by hematoxylin staining.
Statistical Methods
Statistical analyses were performed on sets of area measurement data and nuclear counting data from 26 allografted mice and 8 isografted mice (one section from each animal for each of the two data sets). Immunohistochemical data were statistically analyzed in a selected group of 12 animals comprising 3 mice from each of the three time points studied in the allograft group and 3 mice from the isograft group. Six sections from each animal, stained for a-actin, PCNA, CD45, CD4, CD8, and Mac-1, were analyzed.
When data were consistent with a multivariate normal distribution of errors (Figs 4 and 6 ), they were subjected to a multivariate ANOVA (MANOVA) with one grouping factor (DAY: 7, 15, or 30) and one repeated-measures factor (tissue LOCUS: intima, media, or adventitia). The P4V program of the BMDP Statistical Software package35 was used for this purpose. When the DAY MANOVA factor was significant, individual comparisons between durations (eg, 7 days versus 30 days) were computed with the planned comparisons feature available in P4V. Because each trivariate observation comprised values for surface area, number of nuclei, and number of nuclei per unit area, there were three trivariate observations per data-table cell in the two-factor MANOVA. When the data were inconsistent with a multivariate normal distribution ( Fig 5) , a univariate ANOVA was performed before individual comparisons, which were made only when the DAY ANOVA factor was significant.
This statistical strategy, an application of the "protected test" concept,36 afforded a measure of insurance against spurious differences due to multiple comparisons. The protected test allowed us to set the a level for statistical significance at values of P<.05 for all comparisons. Error estimates (Fig 2A through 2C) compared with sections from a 30-day isograft ( Fig 2D) and a native vessel (Fig 2E) . The day-7 allograft section (Fig 2A) shows a threeto six-cell-deep neointima that thickened rapidly by day 15 (Fig 2B) , to encroach on most of the lumen by day 30 (Fig 2C) . (In fact, in 5 of the 10 day-30 specimens, the neointima almost totally occluded the lumen.) In contrast, the day-30 isograft section shows only a single layer of cells staining for a-actin ( Fig 2D) , luminal to the internal elastic lamina along only part of its circumference. This pattern was observed in 2 of the 8 isograft specimens; the 6 others showed no evidence of neointima and closely resembled the native vessel specimen (Fig 2E) .
There were few a-actin-positive cells in the allograft neointima at day 7 (arrow, Fig 2A) . By day 15, however, about a third of the neointimal cells (those adjacent to the media) stained for a-actin ( Fig 2B) , and by day 30, most of the cells in the neointima were ar-actin-positive ( Fig 2C) . Fig 3A shows that about a third of the neointimal cells at day 7 stained for CD45 and were thus leukocytes. An examination of nuclear morphology indicated that most were mononuclear. By day 15, only the luminal part of the neointima stained for CD45 ( Fig 3B) . Photomicrographs showing cross sections of allografted and isografted vessels: A and B, 7-and 15-day allografts, respectively, stained for the leukocyte marker CD45 (brown); C and D, 15-and 30-day allografts, respectively, stained for proliferating-cell nuclear antigen (dark brown); and E and F, 30-day allograft and 30-day isograft. respectively, stained for von Willebrand factor (dark brown, arrows) (methyl green counterstaining, paraffin embedded, original magnification x250). comparison between Fig 3B and Fig 2B. it appears that the cells that did not stain for CD45 were a-actinpositive. Fig 3C shows that at day 15 there was abundant cellular proliferation among the luminal cells, as indicated by staining for PCNA. Some PCNA staining persisted at dav 30 (Fig 3D) . Since most of the neointimal cells at day 30 were smooth muscle cells (as judged bh staining for a-actin). it is likelx that these are the same cells that were PCNA-positive and therefore were proliferating.
Area measurements and cell counting confirmed these visual impressions of intimal change. Allografts showed a generallv concentric and progressive increase in the intimal area. beginning at 10.31±5.14 gm at day 7 and extending to 28.82+2)0.78 gm (P=NS) at dav 15 and 68.3+23.4 gm' at day 30 (P=.0002. dav 15 versus dav 30). The difference in area between days 7 and 30 was also significant (P<.0005) ( Fig 4A) . The neointima showed a progressive increase in the number of nuclei, from 208+74 at day 7 to 445123() at dav 15 (P=.025) and 783±217 at day 30 (P=.001. day 15 versus day 30) ( Fig 4B) . Cell density (expressed as the number of nuclei per square micrometer) decreased in the intima bv day 30. a time when the intimal area was greatest (P=.02) ( Fig 4C) . This decrease in density suggests that matrix deposition may have accounted for some of the intimal thickening at this time. At dav 7. few cells in the intima stained for a-actin. but bv dav 30. 80--9% of the (Fig 5A) . At day 7, 29.5±11.3% of the intimal cells stained for CD45 ( Fig  5B) . This amount decreased to 16.2±2.2% by day 30 (P=.05). The percentage of cells in the intima that stained for PCNA reached its maximum at day 15, 29.4±5.7%, and decreased to 13.5±4.0% at day 30 (P=.004) ( Fig 5C) .
To resolve the identity of the leukocytes (CD45+ cells) that made up most of the neointima at day 7, we stained the cells with antibodies to CD4, CD8, and CD11b (which identifies macrophages, monocytes, and granulocytes). The largest number of cells was CD1lb+ (21.4±7.3%). Because staining for CD11b per se cannot be used to differentiate macrophages and monocytes from granulocytes, we examined the nuclear morphology. Most CD11b+ cells had single-lobed rather than multilobed nuclei, indicating that they were macrophages or monocytes rather than granulocytes. Cells staining with antibodies to CD4 (7.2±5.2% of nuclei) and CD8 (11.1±5.2% of nuclei) were less abundant at day 7 than were cells staining for CD11b (P=.05 for CD1lb versus CD8 and P= .007 for CD1lb versus CD4). There was no significant difference between the prevalence of CD4 and CD8 cells at 7 days. There were no significant differences among the numbers of CD11b+, CD4+, and CD8+ cells in the intima at later time points and none in the media or adventitia at any time point. It should also be noted that there were almost no detectable CD11b+, CD4+, or CD8+ cells in the adventitia of the isograft at day 30. These observations in vascular allografts indicate the rapid formation of a neointima that progressed over 30 days to a nearly occlusive lesion. The first cells to infiltrate the neointima appear to have been mononuclear leukocytes (by day 7). By day 15, these cells were joined by a large number of smooth muscle cells, and by Day7 15 30 day 30, most cells in the neointima were smooth muscle cells (which apparently continued to proliferate). The total number of cells continued to increase in the intima from day 7 to day 30, even though cell density decreased. This decrease in density was probably due to an increase in the extracellular matrix (which would account for part of the increase in intimal thickness). Cellular proliferation appeared prominent among the mononuclear leukocytes at day 15 and among the smooth muscle cells at day 30. The initial mononuclear cell infiltrate was dominated by CD11b+ cells, which, on the basis of nuclear form, were probably monocytes or macrophages. Helper and cytotoxic T cells were also present in the initial infiltrate.
Endothelium
Arteriosclerotic changes in the intima occurred without loss of endothelium. Fig 3E shows an intact endothelial layer (revealed by staining for von Willebrand factor) in a 30-day allograft with an exuberant neointima, and Fig 3F shows a similarly intact endothelium in a 30-day isograft with a minimal neointima. These observations indicate that a neointimal lesion can occur without loss to the endothelial layer.
Media
At 7 days, a-actin staining in the allograft media ( Fig  2A) was similar to that in the isograft at 30 days ( Fig  2D) and that in the native vessel (Fig 2E) . By day 15, a-actin staining diminished in the media, and breaks in the elastic lamina became evident (Fig 2B) . At 30 days, there was a complete absence of a-actin-positive cells in some regions of the media (Fig 2C, arrow) . These changes appeared to occur with infiltration of mononuclear leukocytes (CD45 + cells) into the media at day 30 (not shown). At days 15 and 30 (Fig 3C Each point represents the mean+SD from three samples. A, Neointimal a-actin-positive cells increase significantly between day 7 and day 30 (P<.0006), whereas medial a-actin-positive cells decrease (P<.00005). B, Neointimal CD45+ cells decrease between day 7 and day 30 (P=.05), and medial CD45+ cells increase (P=.03). C, Neointimal proliferating-cell nuclear antigen (PCNA)-positive cells decrease between day 15 and day 30 (P=.004). The percentage of cells staining for PCNA in the media did not change significantly with time. respectively), there were also a few PCNA-positive cells in the media. The cross-sectional area of the media did not differ significantly between the day-30 isograft and the day-7 allograft ( Fig 6A) . There was a modest increase from 38.07±4.49 to 53.47±8.90 11m2 (P<.0002) between day 7 and day 15 but no significant increase thereafter. There was no significant change with time in the number of nuclei in the media (Fig 6B) . Nuclear debris appeared in the media in some day-30 specimens.
a-Actin-staining cells in the media decreased from nearly 100% at day 7 to 18±12.6% at day 30 (P<.00005) ( Fig SA) . Medial cells rarely stained for CD45 between days 7 and 15; however, the percentage increased =10-fold to 14.2±8.3% by day 30 (P=.03) ( Fig 5B) . The percentage of cells staining for PCNA in the media did not change significantly with time.
These observations indicate that medial smooth muscle cells were either lost or did not express a-actin with the lengthening of the time the allograft resided in the recipient. Since the number of nuclei in the media did not change significantly, it is likely that smooth muscle cells were replaced by mononuclear leukocytes (as indicated by the late increase in the number of CD45 + cells in the media). The media of an isograft at 30 days was indistinguishable from that of a native vessel (by a-actin staining).
Adventitia
Abundant infiltration of CD45+ cells occurred in the adventitia at days 15 ( Fig 3B) and 30 (not shown). The level of adventitial PCNA-positive cells increased significantly from day 7 to day 15 (1.65±0.08 to 4.16±1.1 nuclei per square micrometer) (P=.003) but then dropped significantly at 30 days to a level no different from that observed at 7 days (0.92±0.14 nuclei per square micrometer) (P= .0007) (Table) . CD45 + cells showed a similar pattern (Table) . The increase in CD45 + cells from day 7 to 15 was significant (P= .0002), as was the drop from day 15 to day 30 (P=.0006). Again, levels at 7 and 30 days were statistically indistinguishable.
These observations are consistent with an early inflammatory response in the allograft adventitia involving mononuclear cells that proliferate. The isografts had few mononuclear cells in the adventitia (not shown). The level of PCNA-positive cells increased significantly at 15 days (P=.003) and then dropped significantly by 30 days to a level not different from that at 7 days (P=.0007). The level of CD45+ cells increased significantly from day 7 to day 15 (P=.0002) and then also dropped from day 15 to day 30 (P=.0006). Again, levels at 7 and 30 days were statistically indistinguishable.
Discussion
The purpose of the present report is to describe a new model for the study of transplant arteriosclerosis in mice. When it is used with strains that have been subjected to targeted gene deletion (see the introductory section), the model may well provide a powerful tool for dissecting the relative contributions that humoral antibodies, specific cytokines or growth factors, cytotoxic T cells, or macrophages make to the pathogenesis of the disease. We chose the mouse because its genetics are the best defined among laboratory mammals and it offers the largest number of lines that manifest specific gene mutations and deletions. Although the murine abdominal cardiac allograft model has been available since 1973, it has largely been applied to the study of acute organ rejection. 37 We decided to transplant the carotid artery instead, because it allows the study of vascular rejection in the absence of surrounding parenchyma. Syngeneic carotid artery transplantation in the rat has been used previously to study the lesion of balloon injury. 38 Carotid arteries are transplanted between syngeneic or allogeneic strains of mice. A neointima begins to develop in allografts as early as 7 days after grafting, and it becomes a nearly occlusive lesion after 30 days. The dominant initial intimal cellular infiltrates are mononuclear leukocytes. Among the mononuclear leukocytes, macrophages or monocytes predominate, followed by helper and cytotoxic T cells. At 15 days, smooth muscle cells join the neointimal infiltrate, and they become dominant at 30 days. Cellular proliferation is a feature of the intimal lesion throughout its course. Cellularity increases from day 7 to day 30, but cellular density decreases, suggesting the deposition of extracellular matrix. Also, these changes occur without loss of endothelium. Isografted arteries generally do not develop a neointima, although in a few cases a neointima of one cell layer develops on just a portion of the luminal circumference. The exuberant neointima seen in allografts, but not in isografts, indicates that it is the product of an immunologically mediated reaction rather than of surgical trauma or ischemia.
The media in allografted arteries loses smooth muscle cells with time, although its cellularity does not change. A late increase in mononuclear leukocytes suggests that inflammatory cells replace smooth muscle cells. This change does not occur in isografts, indicating that it is 20 10 m 0-T T also immunologically mediated. The adventitia is maximally infiltrated with proliferating mononuclear cells at day 15, with some decrease in the infiltration by day 30. Isografts do not show significant infiltration by mononuclear cells in the adventitia.
In many respects, the morphological features of this murine vascular transplant model resemble those of human transplant arteriosclerosis.1l0 The human lesions are also characterized by concentric intimal proliferation, with a dominance of smooth muscle cells in late specimens accompanied by macrophages and T cells. And as in the human and the mouse, intimal thickening impinges on the lumen of the vessel, and inflammatory cells infiltrate the adventitia. Although the loss of smooth muscle cells from the media has not been described in the human lesion, this difference may be related to the use of immunosuppressive agents in clinical transplantation. The loss of smooth muscle cells in the media has also been observed in rat aortic allografts,1639 in which the media becomes essentially acellular after 6 months.
The principal advantage of the murine vascular graft model is that it permits exploitation of the rich genetic resources of murine species with a lesion that develops rapidly: experiments can be completed in <30 days. Other advantages include its similarity to human transplant arteriosclerosis, a staged development of lesions with mixed cellular characteristics involving both inflammatory cell and smooth muscle cell accumulation, and general reproducibility in pattern at each time point. Syngeneic and allogeneic grafts can be compared in the same animal, and with a skilled operator, the experimental success rate is high. Because the common carotid artery is unbranched from its origin in the aorta to its bifurcation, quantification and morphometric studies are simplified. Also, the murine vascular graft procedure, which is carried out subcutaneously in the neck, is not as technically complex as abdominal cardiac transplantation,37 which requires invasion of the peritoneal space with attendant complications. The model's major disadvantage lies in the extended training period required for the operator to become proficient. An interesting contrast between isograft transplantation in the mouse and rat9 14,'5'17 is the absence of very much intimal proliferation in mouse isografts. One reason may be the greater degree of inbreeding in mouse strains.
